Does allspice help with blood pressure, blood clotting or cancer?

Allspice's pharmacology comes from two distinct chemistry layers — a volatile essential oil dominated by eugenol, and a water-soluble polyphenol fraction unique among common spices.

Eugenol-rich essential oil. Across Jamaican, Guatemalan, Mexican, and Indian samples, eugenol consistently makes up 60–90% of allspice essential oil^1,5. Eugenol is the same compound that dominates clove oil, and it carries the same broad pharmacology: dual inhibition of cyclooxygenase and lipoxygenase pathways, vasodilation through nitric oxide signaling, mild antiseptic activity, and inhibition of platelet aggregation at low concentrations.

Ericifolin and the polyphenol fraction. Allspice berries contain water-soluble polyphenols including ericifolin (eugenol 5-O-β-(6'-galloylglucopyranoside)), gallic acid, quercetin glycosides, and other galloylglucosides not found in most other culinary spices^2,3. Ericifolin in particular has emerged from cancer biology research as the compound responsible for the androgen-receptor-silencing activity observed in prostate cancer cell lines².

Cardiovascular effects. In Spontaneously Hypertensive Rats, an aqueous fraction of Pimenta dioica administered intravenously produced a dose-dependent decrease in blood pressure with an ED50 of approximately 45 mg/kg⁴. This work pre-dated the eugenol platelet research but is consistent with the now-established vasodilator and anti-platelet activity of eugenol at low concentrations^7,8.

Antimicrobial activity. Eugenol disrupts bacterial cytoplasmic membranes and interferes with quorum sensing — the chemical signaling that coordinates biofilm formation. Essential oil from Guatemalan allspice leaves showed growth inhibition against two Gram-positive and two Gram-negative bacteria, and eugenol was its main component⁵.

Practical use

Whole allspice berries and ground allspice powder are the standard forms in cooking. The dried berry (about the size of a peppercorn) is used in jerk seasoning, pickling spice, mulled wine, gingerbread, mole sauce, and sausage. Six to eight berries can be lightly toasted and crushed to add to a small pot of grains, beans, or soup. Ground allspice loses volatile eugenol over time — buying whole berries and grinding fresh is meaningfully more potent.

For the eugenol pathway specifically, see our cloves page for parallel evidence on the same active compound. For other polyphenol-rich spices that target inflammation through different pathways, see our bay leaf page and cinnamon page.

Allspice essential oil is concentrated and irritating to skin and mucous membranes — it should not be used undiluted on skin, and ingestion of essential oil drops is not recommended. Culinary allspice is well-tolerated. People taking blood thinners should be aware that high-dose eugenol has measurable anti-platelet effects^7,8, so concentrated supplements warrant caution alongside warfarin or DOACs.

The integrated pharmacology review

Zhang and Lokeshwar (2012)¹ published the most comprehensive synthesis of medicinal research on Pimenta dioica, integrating ethnopharmacology, essential oil chemistry, and the early cancer cell line data emerging from their Miami laboratory. Key documented activities included:

• Antioxidant activity comparable to other eugenol-rich spices on DPPH and ABTS radical-scavenging assays
• Anti-platelet aggregation through eugenol's inhibition of arachidonic acid metabolism
• Antimicrobial activity against Gram-positive and Gram-negative bacteria
• Hypoglycemic and hypotensive effects in rodent models
• Selective antiproliferative activity on prostate, breast, and other cancer cell lines without comparable toxicity to non-tumorigenic cells

The review notes that allspice has been used traditionally in Jamaica and Mexico for digestive complaints, toothache, joint pain, and "high blood" — uses that broadly align with the modern pharmacology of eugenol and the polyphenol fraction. The authors flag the absence of human clinical trials as the major gap, a gap that remained unfilled at time of writing.

Ericifolin and prostate cancer (Shamaladevi 2013)

Shamaladevi et al. (2013)² is the most cited piece of allspice cancer research. The team isolated and characterized a previously poorly studied polyphenol called ericifolin from aqueous allspice extract and tested it in androgen-receptor-positive prostate cancer cell lines (LNCaP, MDA-PCa-2b) and AR-negative lines (PC3) plus mouse xenograft models.

Key findings:

• Aqueous allspice extract (AAE) inhibited LNCaP and MDA-PCa-2b cell proliferation at IC50 values of 40–85 μg/mL with no comparable toxicity to non-tumorigenic prostate epithelial cells
• AAE silenced androgen receptor (AR) transcription, reducing AR mRNA, AR protein, and prostate-specific antigen (PSA) secretion in a dose-dependent manner
• Ericifolin alone reproduced the AR-silencing effect at lower concentrations than crude AAE, identifying it as the active compound
• In LNCaP tumor-bearing nude mice, oral allspice extract delayed tumor growth by approximately 55% over 4 weeks without measurable systemic toxicity (body weight, organ histology, blood chemistry)

Mechanistically, ericifolin worked at the transcription factor level — it inhibited AR promoter activity in luciferase reporter assays, which is upstream of the androgen-blocking drugs currently used clinically (which act at the androgen-binding site rather than transcription). This makes ericifolin pharmacologically distinct from drugs like enzalutamide and bicalutamide.

Limitations: this is preclinical evidence in cell lines and mouse xenografts — there are no human prostate cancer trials of allspice or ericifolin. The mouse data used oral dosing of crude extract at amounts that would translate to high but achievable supplemental human doses. The selectivity for AR-positive cells is biologically interesting but does not yet justify clinical claims.

Triple-negative breast cancer and autophagy (Zhang 2015)

Zhang et al. (2015)³ extended the same group's work to breast cancer using a polyphenol-rich allspice extract on multiple breast cancer cell lines including MDA-MB-231 (triple-negative). Findings:

• Reduced viability and clonogenic growth across estrogen-receptor-positive, HER2-positive, and triple-negative lines, with limited toxicity to non-tumorigenic mammary epithelial cells
• Cytotoxicity was driven by autophagy rather than apoptosis — markers LC3B and LC3B-positive puncta increased dose-dependently, and silencing autophagy genes ATG5 and ATG7 prevented cell death
• Inhibition of Akt/mTOR signaling, the same axis targeted by rapamycin
• Synergistic cytotoxicity when combined with rapamycin in cell culture
• In a triple-negative breast cancer xenograft model in athymic mice, allspice extract pre-treatment for 2 weeks delayed tumor palpability and reduced tumor growth rate by approximately 38%, with tumor tissue analysis confirming elevated LC3B

Triple-negative breast cancer is the subset with the worst prognosis and fewest targeted therapy options, which makes the autophagy mechanism notable: it kills cells through a different pathway than apoptosis-targeting chemotherapies, potentially side-stepping resistance.

Limitations again are preclinical: no human breast cancer trials have been conducted with allspice extract. The extract used was a concentrated polyphenol preparation, not whole spice. The synergy with rapamycin is mechanistically interesting but has not been tested clinically.

Cardiovascular effects in rats (Suárez 2000)

Suárez et al. (2000)⁴ examined the hypotensive activity of allspice in Spontaneously Hypertensive Rats (SHR), the standard genetic rodent model of hypertension. Bioassay-guided fractionation of an aqueous Pimenta dioica extract isolated a final aqueous fraction that, when administered intravenously, produced a dose-dependent fall in mean arterial pressure with an ED50 of 45 mg/kg.

The hypotensive response was rapid (within minutes of injection) and sustained, suggesting a direct vascular mechanism rather than diuresis. The authors did not identify a single active compound but noted that the activity was retained in polar fractions, consistent with the water-soluble polyphenol fraction rather than the volatile essential oil.

This is acute intravenous data in anesthetized rats and does not directly speak to dietary or oral supplemental effects in humans. However, it is biologically consistent with the now-established vasodilator activity of eugenol and the polyphenol pathways characterized in subsequent platelet research.

Eugenol, platelets, and thrombosis (Huang 2024, Chang 2024)

Two 2024 papers on eugenol bracket the cardiovascular pharmacology of allspice's principal essential oil compound. Huang et al. (2024)⁷ showed that eugenol at a low concentration (2 μM) inhibited collagen and arachidonic-acid-induced platelet aggregation in human platelets and reduced pulmonary thromboembolism in murine models. The mechanism involved inhibition of the PLCγ2-PKC signaling cascade, with effects on intracellular calcium levels in platelets.

Chang et al. (2024)⁸ characterized a parallel pathway — eugenol inhibition of cytosolic phospholipase A2 (cPLA2) and downstream NF-κB signaling in human platelets, with corresponding reduction in mesenteric vascular thrombus formation in fluorescein-irradiated mice. The cPLA2-NF-κB axis links platelet activation to inflammatory signaling, suggesting eugenol works at a node where thrombosis and inflammation intersect.

These are mechanistic and animal studies — they do not show that eating allspice meaningfully alters cardiovascular outcomes in humans. They do, however, establish biological plausibility for the traditional cardiovascular uses and validate the concern that high-dose eugenol concentrates could interact with anti-platelet medications.

Antimicrobial activity (Mérida-Reyes 2020)

Mérida-Reyes et al. (2020)⁵ characterized the essential oil from Guatemalan Pimenta dioica leaves and fruits. Eugenol was the main component, at 65.9–71.4% of the oil.

Antibacterial testing of the leaf oil showed growth inhibition against two Gram-positive and two Gram-negative bacteria, and the authors suggested that the leaves could be evaluated as a source of ingredients for antiseptic products.

Anti-SARS-CoV-2 and anti-inflammatory activity (El Gizawy 2021)

El Gizawy et al. (2021)⁶ isolated four compounds from Pimenta dioica leaves — ferulic acid, rutin, gallic acid, and chlorogenic acid — and tested them across molecular docking, in vitro, and in vivo platforms. Docking and dynamics simulations against the SARS-CoV-2 main protease (Mpro) were used to propose a mechanism of action, and rutin, gallic acid, and chlorogenic acid showed anti-SARS-CoV-2 activity in vitro (IC50 values of 31 µg/mL, 108 μg/mL, and 360 µg/mL, respectively). In rats with lung toxicity induced by mercuric chloride, the P. dioica aqueous extract and the four compounds were tested for effects on inflammatory cytokine and microRNA levels, and the anti-inflammatory effects were better with ferulic acid and rutin.

This study is mechanistically broad but should be read carefully — the SARS-CoV-2 work is in silico and in vitro, not clinical, and the anti-inflammatory effects in animals match what is already known about other plant polyphenols. The contribution is identifying which specific allspice polyphenols carry the activity, and providing additional mechanistic support for traditional anti-inflammatory uses of the spice.

Strength of evidence

The evidence base for allspice is unusual in its asymmetry: one focused research group (Lokeshwar lab at Miami) has produced a concentrated set of preclinical cancer studies on a unique polyphenol (ericifolin), while the broader pharmacology rests on the well-established eugenol literature derived mostly from clove research. There are essentially no human clinical trials of allspice or ericifolin as of the most recent literature reviewed.

What this means in practice:

• Culinary use of allspice is well-tolerated and provides modest amounts of eugenol and polyphenols with biologically plausible cardiovascular and anti-inflammatory effects, though the dietary contribution is small relative to therapeutic doses studied
• Concentrated allspice extracts and ericifolin remain investigational — the prostate and breast cancer findings are scientifically interesting but should not be used as the basis for replacing standard treatment
• The anti-platelet pharmacology of eugenol is strong enough that high-dose supplements warrant the same caution as other natural anti-platelet agents (garlic, ginger, ginkgo) for people on blood thinners
• The antimicrobial and food preservation applications of allspice essential oil have the most direct practical relevance, with eugenol acting through both bactericidal and quorum sensing mechanisms